CCM
TMDX icon

Chilton Capital Management’s Transmedics TMDX Stock Holding History

Chilton Capital Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.96K Hold
150
– – ﹤0.01% 459
2026
Q1 		$14.9K Hold
150
– – ﹤0.01% 436
2025
Q4 		$18.2K Hold
150
– – ﹤0.01% 419
2025
Q3 		$16.8K Sell
150
-150
-50% -$17.6K ﹤0.01% 450
2025
Q2 		$40.2K Hold
300
– – ﹤0.01% 352
2025
Q1 		$20.2K Hold
300
– – ﹤0.01% 408
2024
Q4 		$18.7K Buy
+300
New +$27.9K ﹤0.01% 415

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Chilton Capital Management's TMDX Position: Q2 2026 in Review

Chilton Capital Management held its Transmedics (TMDX) position steady in Q2 2026 at 150 shares worth $9.96K. The position accounts for ﹤0.01% of the portfolio, ranked #459.

Chilton Capital Management first reported a position in TMDX in Q4 2024 and has held it in 7 quarters since. The position peaked at $40.2K in Q2 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Chilton Capital Management held 150 shares of Transmedics worth $9.96K as of Q2 2026.
  • Chilton Capital Management left its Transmedics share count unchanged in Q2 2026.
  • Transmedics made up ﹤0.01% of Chilton Capital Management's portfolio in Q2 2026, its #459 holding.
  • Chilton Capital Management first reported a position in Transmedics in Q4 2024 and has held it in 7 quarters since.
  • Chilton Capital Management's Transmedics position peaked at $40.2K in Q2 2025.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Chilton Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.